6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

7 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02879136 (ClinicalTrials.gov)	December 2016	23/6/2016	TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease	TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease: A Single Center, Randomized Pilot Study	Parkinson's Disease, Idiopathic	Drug: Methylphenidate;Other: Physical Therapy;Drug: Atomoxetine	Hubert Fernandez	NULL	Recruiting	18 Years	90 Years	All	42	Early Phase 1	United States
2	NCT01244269 (ClinicalTrials.gov)	December 2010	18/11/2010	The Effect of Methylphenidate on Non-motor Symptoms and Postural Control in Parkinson's Disease.	Two-phase Randomized Controlled Trial of Low and Moderate Dose Methylphenidate for Non-motor and Postural Symptoms in Parkinson's Disease.	Parkinson's Disease	Drug: Methylphenidate;Drug: Placebo 10;Drug: Placebo 20	Laval University	Fonds de la Recherche en Santé du Québec;Quebec Memory and Motor Skills Disorders Research Center	Terminated	N/A	75 Years	Both	6	Phase 4	Canada
3	EUCTR2009-012643-42-NL (EUCTR)	06/01/2010	30/11/2009	Freezing of gait in Parkinson's disease: in search of the underlying mechanism and the application of a new treatment option - Freezing of gait in Parkinson's disease	Freezing of gait in Parkinson's disease: in search of the underlying mechanism and the application of a new treatment option - Freezing of gait in Parkinson's disease	Parkinson's disease, in particular the symptom Freezing of Gait	Trade Name: Ritalin Product Name: Not applicable Product Code: Not applicable INN or Proposed INN: METHYLPHENIDATE HYDROCHLORIDE Other descriptive name: Ritalin	University Medical Center Groningen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Netherlands
4	NCT00914095 (ClinicalTrials.gov)	October 2009	2/6/2009	Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)	Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentric Trial	Parkinson's Disease;Gait Disorders, Neurologic;Dementia	Drug: methylphenidate;Drug: placebo	University Hospital, Lille	NULL	Completed	30 Years	80 Years	Both	69	Phase 4	France
5	NCT00526630 (ClinicalTrials.gov)	December 2007	5/9/2007	Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease	Methylphenidate for the Treatment of Gain Impairment in Parkinson's Disease: a Randomized Double-Blind, Placebo-Controlled, Cross-over Study	Parkinson's Disease;Gait Impairment	Drug: Methylphenidate (MPD);Drug: Placebo	University of Cincinnati	Michael J. Fox Foundation for Parkinson's Research	Completed	35 Years	85 Years	All	23	Phase 4	United States
6	NCT00393562 (ClinicalTrials.gov)	March 2006	26/10/2006	Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease	Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease	Parkinson's Disease	Drug: modafinil;Drug: methylphenidate	Department of Veterans Affairs	NULL	Withdrawn	50 Years	80 Years	Both	0	N/A	United States
7	NCT00359723 (ClinicalTrials.gov)	July 2004	31/7/2006	Methylphenidate and Parkinson's Disease	Subacute Trial of Methylphenidate in Parkinson's Disease	Parkinson's Disease	Drug: methylphenidate	Oregon Health and Science University	National Institute of Neurological Disorders and Stroke (NINDS)	Completed	21 Years	N/A	All	13	Phase 2	United States

先頭へ